Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)

OBJECTIVES: Alterations in dopamine neurotransmission underlie some of the clinical features of Huntington’s disease (HD) and as such are a target for therapeutic intervention, especially for the treatment of chorea and some behavioural problems. However, justification for such an intervention is ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Kate L, Kuan, Wei-Li, Mason, Sarah L, Barker, Roger A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279191/
https://www.ncbi.nlm.nih.gov/pubmed/32229581
http://dx.doi.org/10.1136/jnnp-2019-322038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279191/
https://www.ncbi.nlm.nih.gov/pubmed/32229581
http://dx.doi.org/10.1136/jnnp-2019-322038

Ejemplares similares